Boston Scientific Corporation (BSX) vs Cardinal Health, Inc. (CAH)
A side-by-side comparison of Boston Scientific Corporation and Cardinal Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$45.05HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT
CAH
Cardinal Health, Inc.
$234.89HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT
Total return — BSX vs CAH
growth of $100 · dividends reinvested · last 10yBSX +82.8% (+6.2%/yr)CAH +304.7% (+15.0%/yr)CAH compounded faster over this window
BSX CAH
BSX vs CAH: by the numbers
- •BSX is the larger company ($66.96B vs $55.01B market cap).
- •BSX trades at the lower trailing earnings multiple (18.31 vs 32.49 P/E), one valuation lens rather than an overall verdict.
- •BSX converts more revenue to profit (17.47% vs 0.67% net margin).
- •BSX grew revenue faster over the past five years (13.40% vs 9.37% CAGR).
- •CAH pays a dividend (0.87% yield), while BSX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BSX | CAH |
|---|---|---|
| P/E ratio | 18.31 | 32.49 |
| Forward P/E | 13.70 | 18.72 |
| P/S ratio | 3.19 | 0.22 |
| P/B ratio | 2.69 | N/A |
| EV / EBITDA | 13.64 | 16.84 |
| FCF yield | 5.41% | 8.23% |
Profitability
| Metric | BSX | CAH |
|---|---|---|
| Gross margin | 71.16% | 3.84% |
| Operating margin | 21.46% | 1.03% |
| Net margin | 17.47% | 0.67% |
| ROE | 14.71% | N/A |
| ROIC | 10.57% | 13.45% |
Dividends
| Metric | BSX | CAH |
|---|---|---|
| Dividend yield | N/A | 0.87% |
| Payout ratio | N/A | 28.33% |
Growth (annualized)
| Metric | BSX | CAH |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 9.37% |
| EPS CAGR (5Y) | N/A | 28.32% |
| FCF CAGR (5Y) | 15.64% | 17.40% |
| Total return CAGR (5Y) | -0.67% | 37.70% |
Frequently asked
- Which has the lower trailing P/E, BSX or CAH?
- BSX has the lower trailing P/E: BSX trades at 18.31 and CAH at 32.49. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BSX or CAH?
- Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus CAH at 9.37%.
- Does BSX or CAH pay a bigger dividend?
- CAH pays a dividend (0.87% yield), while BSX has no payments in the available dividend history.
- Is BSX or CAH more profitable?
- BSX runs the higher net margin — BSX at 17.47% versus CAH at 0.67%.
- How have BSX and CAH total returns compared?
- Over the past 10 years, BSX delivered 6.22% and CAH delivered 14.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioCardinal Health P/E ratioCardinal Health dividend yieldBoston Scientific ROECardinal Health ROEBoston Scientific operating marginCardinal Health operating marginBoston Scientific revenue growthCardinal Health revenue growthBoston Scientific free cash flowCardinal Health free cash flow
Boston Scientific & Cardinal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.